Investing
The latest inflation data provided by the U.S. government this week showed retail and wholesale prices continuing to stabilize and even fall in some...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
Investing
Published: March 3, 2025 at 5:34 p.m. ET A backlash over President Donald Trump’s plan to include three small and relatively risky tokens in an...
Investing
Published: Feb. 27, 2025 at 1:23 p.m. ET AMC Entertainment Holdings Inc.’s most liquid bond rallied this week, lifted by better-than-expected fourth-quarter revenue at the...
Investing
Last Updated: March 3, 2025 at 10:21 p.m. ETFirst Published: March 3, 2025 at 4:58 p.m. ET Kids who are obsessed with football may dream of...
Investing
Opinion: Stay defensive, with lots of cash: This mutual fund giant is cautious about markets in 2024
Every year around this time, the giant Baltimore-based investment shop T. Rowe Price Group TROW sends investment managers and strategists to New York City...
Investing
Thanksgiving is a time to loosen your belt. That’s why, each year around Thanksgiving, I loosen my stock-valuation belt a little in this column,...
Investing
News that hundreds of OpenAI staff are threatening to leave in the wake of Sam Altman’s shock ouster from the ChatGPT maker marks the...
Investing
Key News Asian equities were mixed overnight as Hong Kong outperformed the region. Expectations the US interest rate hiking cycle is over fueled China’s...
Investing
Most large cryptocurrencies were up during morning trading on Monday, with Cardano Cardano USD seeing the biggest change, rising 3.07% to 39 cents. Six...
Investing
Some change is slow. Living wage, defined as sufficient to afford a decent standard of living for the worker and his or her family...
Investing
Citigroup Inc. on Monday said it has informed employees of a “next layer of changes” under Chief Executive Jane Fraser’s plan to streamline the...
Investing
By Sherry Qin Xiaomi Corp. is scheduled to report its third-quarter results Monday after the market close. Here’s what you need to know: NET...
Investing
By Helena Smolak Bayer is discontinuing early a Phase 3 study to test investigational drug asundexian on prevention of stroke and systemic embolism for...
